INTERNATIONAL PATENT: NEXTPOINT THERAPEUTICS, INC. FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATES"

GENEVA, March 19 -- NEXTPOINT THERAPEUTICS, INC. (238 Main Street, 5th FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2024/045733) for "ANTIBODY-DRUG CONJUGATES" on Sep 06, 2024. With publication no. WO/2025/054560, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ETEMAD-GILBERTSON, Bijan (c/o NextPoint Therapeutics, Inc.238 Main Street, 5th FloorCambridge, Massachusetts 02142), CHARI, Ravi (c/o NextPoint Therapeutics, Inc.238 Main Street, 5th FloorCambridge, Massachusetts 02142)

Abstract: Among ...